Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yehuda Handelsman

Showing results (71-80 of 157) with videos related to

Pageof 16
Sort By:
Journal of Diabetes|October 15, 2010
Iron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the USEarl S Ford, Catherine C Cowie, Chaoyang Li, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 23, 2013
The role of bromocriptine-QR in the management of type 2 diabetes expert panel recommendationsAlan J Garber, Lawrence Blonde, Zachary T Bloomgarden, et al.
Postgraduate Medicine|November 27, 2009
Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetesYehuda Handelsman, Stacey L Abby, Xiaoping Jin, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 20, 2013
Reduced risk of hypoglycemia with insulin degludec versus insulin glargine in patients with type 2 diabetes requiring high doses of basal insulin: a meta-analysis of 5 randomized begin trialsHelena W Rodbard, Stephen Gough, Wendy Lane, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 2, 2018
EFFICACY AND SAFETY OF IDEGLIRA IN OLDER PATIENTS WITH TYPE 2 DIABETESIldiko Lingvay, Yehuda Handelsman, Sultan Linjawi, et al.
Postgraduate Medicine|August 24, 2012
Initial combination therapy with metformin plus colesevelam in drug-naïve Hispanic patients with early type 2 diabetesJulio Rosenstock, Eric Hernandez-Triana, Yehuda Handelsman, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 30, 2015
PATIENTS ACHIEVING GOOD GLYCEMIC CONTROL (HBA1c <7%) EXPERIENCE A LOWER RATE OF HYPOGLYCEMIA WITH INSULIN DEGLUDEC THAN WITH INSULIN GLARGINE: A META-ANALYSIS OF PHASE 3A TRIALSDaniel Einhorn, Yehuda Handelsman, Bruce W Bode, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 1, 2009
Effects of colesevelam, rosiglitazone, or sitagliptin on glycemic control and lipid profile in patients with type 2 diabetes mellitus inadequately controlled by metformin monotherapyScott P Rigby, Yehuda Handelsman, Yu-Ling Lai, et al.
Patient Preference and Adherence|June 14, 2019
Divergence in perceptions of diabetes control among patients with type 2 diabetes mellitus treated with basal insulin and health care professionals: results from the US Perceptions of Control (POC-US) studyKenneth J Tomaszewski, Amy Allen, Michelle Mocarski, et al.
Diabetes Care|July 23, 2014
Efficacy and safety of the once-weekly GLP-1 receptor agonist albiglutide versus sitagliptin in patients with type 2 diabetes and renal impairment: a randomized phase III studyLawrence A Leiter, Molly C Carr, Murray Stewart, et al.
Pageof 16

Showing results (71-80 of 157) with videos related to

Sort By:
Pageof 16
Journal of Diabetes|October 15, 2010
Iron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the USEarl S Ford, Catherine C Cowie, Chaoyang Li, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 23, 2013
The role of bromocriptine-QR in the management of type 2 diabetes expert panel recommendationsAlan J Garber, Lawrence Blonde, Zachary T Bloomgarden, et al.
Postgraduate Medicine|November 27, 2009
Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetesYehuda Handelsman, Stacey L Abby, Xiaoping Jin, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 20, 2013
Reduced risk of hypoglycemia with insulin degludec versus insulin glargine in patients with type 2 diabetes requiring high doses of basal insulin: a meta-analysis of 5 randomized begin trialsHelena W Rodbard, Stephen Gough, Wendy Lane, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 2, 2018
EFFICACY AND SAFETY OF IDEGLIRA IN OLDER PATIENTS WITH TYPE 2 DIABETESIldiko Lingvay, Yehuda Handelsman, Sultan Linjawi, et al.
Postgraduate Medicine|August 24, 2012
Initial combination therapy with metformin plus colesevelam in drug-naïve Hispanic patients with early type 2 diabetesJulio Rosenstock, Eric Hernandez-Triana, Yehuda Handelsman, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 30, 2015
PATIENTS ACHIEVING GOOD GLYCEMIC CONTROL (HBA1c <7%) EXPERIENCE A LOWER RATE OF HYPOGLYCEMIA WITH INSULIN DEGLUDEC THAN WITH INSULIN GLARGINE: A META-ANALYSIS OF PHASE 3A TRIALSDaniel Einhorn, Yehuda Handelsman, Bruce W Bode, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 1, 2009
Effects of colesevelam, rosiglitazone, or sitagliptin on glycemic control and lipid profile in patients with type 2 diabetes mellitus inadequately controlled by metformin monotherapyScott P Rigby, Yehuda Handelsman, Yu-Ling Lai, et al.
Patient Preference and Adherence|June 14, 2019
Divergence in perceptions of diabetes control among patients with type 2 diabetes mellitus treated with basal insulin and health care professionals: results from the US Perceptions of Control (POC-US) studyKenneth J Tomaszewski, Amy Allen, Michelle Mocarski, et al.
Diabetes Care|July 23, 2014
Efficacy and safety of the once-weekly GLP-1 receptor agonist albiglutide versus sitagliptin in patients with type 2 diabetes and renal impairment: a randomized phase III studyLawrence A Leiter, Molly C Carr, Murray Stewart, et al.
Pageof 16